Patent · US Active

Composition comprising scirpusin A and scirpusin B and anti-adipogenesis/anti-obesity potential thereof

US9387193B2 · kind B2 · utility

0Cited by

0References

4Claims

0Family size

Assignee

SAMI LABS LIMITED · IN

Inventors

Muhammed Majeed · Plainsboro, US
Kalyanam Nagabhushanam · Plainsboro, US
Douglas Kalman · Weston, US
Beena Bhat · Bengaluru, IN
Priti Vaidyanathan · Bengaluru, IN
Sarang Bani · Bengaluru, IN
Anjali Pandey · Fremont, US

Key dates

Filing date	Jul 17, 2013
Grant date	Jul 12, 2016
Priority date	—
Expiry date	Oct 2, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P3/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is a composition comprising scirpusin A and scirpusin B and anti-obesity potential thereof. Also disclosed are methods of inhibiting adipogenesis using a composition comprising scirpusin A and scirpusin B. The present invention also disclosed methods of therapeutically managing obesity in mammals using a composition comprising scirpusin A and scirpusin B. Still further, the present invention also relates to a method of obtaining compositions comprising A. scirpusin A and scirpusin B and B. piceatannol and its dimers scirpusin A and scirpusin B through bioactivity guided fractionation of the rhizomes of Cyperus rotundus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.